SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 143 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $702,756 | +7.8% | 30,396 | +22.3% | 0.00% | – |
| Q2 2023 | $651,856 | +41.5% | 24,861 | +38.9% | 0.00% | – |
| Q1 2023 | $460,642 | -12.3% | 17,896 | -11.3% | 0.00% | – |
| Q4 2022 | $525,038 | -8.5% | 20,186 | +0.2% | 0.00% | – |
| Q3 2022 | $574,000 | +21.9% | 20,137 | +5.2% | 0.00% | – |
| Q2 2022 | $471,000 | -54.9% | 19,142 | +3.5% | 0.00% | – |
| Q1 2022 | $1,045,000 | -71.2% | 18,498 | -68.4% | 0.00% | -100.0% |
| Q4 2021 | $3,631,000 | -32.5% | 58,584 | -30.9% | 0.00% | 0.0% |
| Q3 2021 | $5,381,000 | -38.7% | 84,807 | -20.4% | 0.00% | -50.0% |
| Q2 2021 | $8,777,000 | +21.8% | 106,499 | +8.7% | 0.00% | 0.0% |
| Q1 2021 | $7,209,000 | +2255.9% | 97,993 | +2221.6% | 0.00% | – |
| Q4 2020 | $306,000 | – | 4,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $272,679,000 | 26.48% |
| Boxer Capital, LLC | 2,075,905 | $117,164,000 | 6.02% |
| Orbimed Advisors | 6,028,307 | $340,238,000 | 5.52% |
| Perceptive Advisors | 4,527,993 | $255,560,000 | 5.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 460,025 | $25,964,000 | 3.67% |
| Affinity Asset Advisors, LLC | 247,000 | $13,941,000 | 2.23% |
| Artal Group S.A. | 850,000 | $47,974,000 | 2.01% |
| Affinity Asset Advisors, LLC | 160,000 | $9,030,000 | 1.44% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,841,799 | $103,951,000 | 1.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 125,000 | $7,055,000 | 1.00% |